sulforaphane has been researched along with Left Ventricular Hypertrophy in 2 studies
sulforaphane: from Cardaria draba L.
sulforaphane : An isothiocyanate having a 4-(methylsulfinyl)butyl group attached to the nitrogen.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wu, QQ | 1 |
| Zong, J | 1 |
| Gao, L | 1 |
| Dai, J | 1 |
| Yang, Z | 1 |
| Xu, M | 1 |
| Fang, Y | 1 |
| Ma, ZG | 1 |
| Tang, QZ | 1 |
| Bai, Y | 1 |
| Cui, W | 1 |
| Xin, Y | 1 |
| Miao, X | 1 |
| Barati, MT | 1 |
| Zhang, C | 1 |
| Chen, Q | 1 |
| Tan, Y | 1 |
| Cui, T | 1 |
| Zheng, Y | 1 |
| Cai, L | 1 |
2 other studies available for sulforaphane and Left Ventricular Hypertrophy
| Article | Year |
|---|---|
Sulforaphane protects H9c2 cardiomyocytes from angiotensin II-induced hypertrophy.
Topics: Angiotensin II; Animals; Cardiotonic Agents; Cell Line; Cell Size; Cell Survival; Dose-Response Rela | 2014 |
Prevention by sulforaphane of diabetic cardiomyopathy is associated with up-regulation of Nrf2 expression and transcription activation.
Topics: Animals; Catalase; Cell Line; Connective Tissue Growth Factor; Diabetes Mellitus, Experimental; Diab | 2013 |